Quote of the Week - Health Canada: Knowledge Driven Revolution

"Health Canada experts are currently working with the manufacturers to standardize this information in order to ensure consistency within North American labelling"
Health Canada

ADHD drug makers in U.S. told to warn patients of heart, mental risks

Runner Up "Eggs are already a highly prized commodity, two-hundred fifty pounds fails on all counts: it is enough to entice women from poorer countries while failing to represent the market value of eggs." - Anna Smajdor, a medical ethics researcher at London's Imperial College

[KDR: Get used to hearing signs of the North American Union like this as they start to bring this merger to the public's attention.]

Drugs prescribed to treat attention deficit hyperactivity disorder will include guides in the United States to alert patients and parents to the risks of mental and heart problems, including sudden death.

The U.S. Food and Drug Administration said Wednesday that it directed the manufacturers of Ritalin, Adderall, Strattera and all other ADHD drugs to develop the guides.

In May 2006, the agency told manufacturers to revise the labels of the drugs to reflect concerns about the cardiovascular and psychiatric problems.

Last May, Health Canada warned of heart risks related to the drugs. In September, it revised its prescribing and patient information to warn of "potential for psychiatric adverse events."

"Health Canada experts are currently working with the manufacturers to standardize this information in order to ensure consistency within North American labelling," a spokesman said Wednesday in an e-mail interview.

"The exact wording has not yet been finalized with manufacturers."

Draft versions of the U.S. guides posted on the FDA website include discussion of reports of increased blood pressure and heart rate in ADHD patients, as well as cases of sudden death in some who have heart problems and heart defects.

In adult patients, the reported problems also include stroke and heart attack.

The alerts also cover psychiatric problems, such as hearing voices, unfounded suspicions and manic behaviour, of which there is a slightly increased risk in patients who take the drugs, the FDA said. The guides tell patients and their parents of precautions they can take to guard against the risks.

Wednesday's announcement came roughly a year after two panels of FDA advisers recommended that the drugs include such patient medication guides. The announcement covers 15 drugs, including extended-release, patch and chewable versions of some of them.

Ritalin is manufactured by Novartis Pharmaceuticals Corp. and in generic form by other companies; Adderall is made by Shire Pharmaceuticals Inc.; Strattera by Eli Lilly & Co.

ADHD affects an estimated three per cent to seven per cent of school-age children and four per cent of adults, the FDA said.

Read the full article here

Broken Link? If the link to the original article is broken or has been altered you can view the article by clicking here.

Read Today's Knowledge Driven News
HOME George Bush Sr. The New World Order Parrot Party Police, Party Courts and Concentration Camps P3s, Nazis and Polite Canadian Fascism The Ghost in the Machine - The Forced Chemical Evolution of Man Rouge States and the 9/11 Truth Terrorists Canadians Should Pay NOT to be Poisoned: NDP V for Vendetta - R for Reality Canadian Bird Flu Pandemic Looming ? Shill of the Week: Stephan Harper Aspartame: The Sweetest Killer Chicken Little Terrorist of the Week: Creating Fake Terrorists Shill of the Week: Paul Martin The Number 1 Reason YOU became a Slave	Quote of the Week: Health Canada *"Health Canada experts are currently working with the manufacturers to standardize this information in order to ensure consistency within North American labelling"* Health Canada ADHD drug makers in U.S. told to warn patients of heart, mental risks AP February 26, 2007 Runner Up "Eggs are already a highly prized commodity, two-hundred fifty pounds fails on all counts: it is enough to entice women from poorer countries while failing to represent the market value of eggs." - Anna Smajdor, a medical ethics researcher at London's Imperial College [KDR: Get used to hearing signs of the North American Union like this as they start to bring this merger to the public's attention.] Drugs prescribed to treat attention deficit hyperactivity disorder will include guides in the United States to alert patients and parents to the risks of mental and heart problems, including sudden death. The U.S. Food and Drug Administration said Wednesday that it directed the manufacturers of Ritalin, Adderall, Strattera and all other ADHD drugs to develop the guides. In May 2006, the agency told manufacturers to revise the labels of the drugs to reflect concerns about the cardiovascular and psychiatric problems. Last May, Health Canada warned of heart risks related to the drugs. In September, it revised its prescribing and patient information to warn of "potential for psychiatric adverse events." "Health Canada experts are currently working with the manufacturers to standardize this information in order to ensure consistency within North American labelling," a spokesman said Wednesday in an e-mail interview. "The exact wording has not yet been finalized with manufacturers." Draft versions of the U.S. guides posted on the FDA website include discussion of reports of increased blood pressure and heart rate in ADHD patients, as well as cases of sudden death in some who have heart problems and heart defects. In adult patients, the reported problems also include stroke and heart attack. The alerts also cover psychiatric problems, such as hearing voices, unfounded suspicions and manic behaviour, of which there is a slightly increased risk in patients who take the drugs, the FDA said. The guides tell patients and their parents of precautions they can take to guard against the risks. Wednesday's announcement came roughly a year after two panels of FDA advisers recommended that the drugs include such patient medication guides. The announcement covers 15 drugs, including extended-release, patch and chewable versions of some of them. Ritalin is manufactured by Novartis Pharmaceuticals Corp. and in generic form by other companies; Adderall is made by Shire Pharmaceuticals Inc.; Strattera by Eli Lilly & Co. ADHD affects an estimated three per cent to seven per cent of school-age children and four per cent of adults, the FDA said. Read the full article here Broken Link? If the link to the original article is broken or has been altered you can view the article by clicking here. About KDR \| \| Home \| \| Weekly Features Archive	Weekly Features Archive What Is Wrong With Canada ? Recent 9-11 News Suppressed by the Media Aspartame: The Sweetest Killer The Number 1 Reason YOU became a Slave Knowledge Driven Look at Your Favourite Canadian Political Parties Read Today's Knowledge Driven News
		Counter
Copyright � 2005-7 KnowledgeDrivenRevolution.com

Quote of the Week: Health Canada

ADHD drug makers in U.S. told to warn patients of heart, mental risks